RWJ PRESIDENT AND CEO STEPHEN K. JONES TO RECEIVE MOTOLINSKY RESEARCH FOUNDATION DISTINGUISHED SERVICE AWARD
September 29, 2011
NEW BRUNSWICK, N.J. - Stephen K. Jones, FACHE, President and Chief Executive Officer of Robert Wood Johnson University Hospital and Robert Wood Johnson Health System, will receive the Melvyn H. Motolinsky Research Foundation’s 2011 Distinguished Service Award.
The award will be presented at the Foundation’s annual board dinner meeting, which takes place in October in New Brunswick. The Motolinsky Foundation was established as a living memorial to Melvyn H. Motolinsky, a New Brunswick lawyer who died of leukemia at age 26 in 1969. The Foundation supports hematology research to develop new treatments and find a cure for leukemia and other blood-related diseases.
For more than 35 years, the Foundation has granted its annual Distinguished Service Award to honorees for outstanding service to the community. Last year’s recipient was Michael Nissenblatt, M.D., a renowned oncologist who currently serves as a Clinical Professor at UMDNJ-Robert Wood Johnson Medical School and Associate Director of Oncology at Robert Wood Johnson University Hospital. Other past recipients include state Senator Joseph Vitale; Rutgers University President Richard McCormick; and Dr. Clifton Lacy, former New Jersey Commissioner of Health and Senior Services and former RWJUH President.
Jack Borrus, Treasurer and one of the founding members of the Motolinsky Foundation, says Mr. Jones was selected because “he personifies the dynamic leadership which has expanded the world-class medical treatment and medical research at Robert Wood Johnson University Hospital.”
According to Mr. Borrus, the Motolinsky Foundation has established the following funds to support medical research and clinical treatment: $250,000 for the Melvyn H. Motolinsky Hematology Laboratory; $500,000 for the annual Melvyn & Ab Motolinsky Hematology Fellowship and $1.25 million for the Melvyn, Ab & Yetta Motolinsky Chair of Hematology, all of which are located at the UMDNJ-Robert Wood Johnson Medical School.” The income from these funds is used to support the Laboratory, the annual fellowship and the professorship in hematology.
“Considering the long list of distinguished past recipients of this award, I am honored and humbled by my selection,” Mr. Jones says. “At Robert Wood Johnson University Hospital, we work closely with our partners at UMDNJ-Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to pioneer research and improve the overall quality of care for our patients. The Motolinsky Foundation has made a significant contribution and has been a tremendous supporter of research and physician training in the hematology field. The generous support of philanthropic organizations like the Motolinsky Foundation is essential to helping us achieve our research goals.”
Mr. Jones, who has more than 30 years health care management experience, began his career at RWJUH in 1983 as a Senior Vice President of Operations, when the hospital began both its clinical and physical transformation into the major regional academic medical center that it is today. He was appointed President and Chief Executive Officer of RWJUH in September 2007 after serving as its Interim President and Chief Executive Officer for one year. Mr. Jones received his Bachelor of Science degree in Finance from the University of Maryland in 1973 and earned a Master of Arts in Health Care Administration from George Washington University in 1976. Prior to joining Robert Wood Johnson University Hospital, Mr. Jones was Assistant Director at Somerset Medical Center from 1979 to 1982 and Assistant Director at Barnert Memorial Hospital Center, Paterson, from 1974 to 1979.
Since being named President and CEO in 2007, Mr. Jones has placed a renewed emphasis on enhancing quality, expanding community outreach and improving customer engagement. Additionally, under his leadership, the hospital continues to perform well financially. For example, despite the very uncertain conditions in the health care industry nationally, RWJUH’s debt has been affirmed by Moody’s as “A2”, while Standard and Poor’s (S&P) just recently increased RWJ’s rating to “A.”
About RWJBarnabas Health
RWJBarnabas Health is the most comprehensive health care delivery system in New Jersey, treating over 3 million patients a year. The system includes eleven acute care hospitals – Clara Maass Medical Center in Belleville, Community Medical Center in Toms River, Jersey City Medical Center in Jersey City, Monmouth Medical Center in Long Branch, Monmouth Medical Center Southern Campus in Lakewood, Newark Beth Israel Medical Center in Newark, RWJUH in New Brunswick and Somerville, RWJUH- Hamilton, RWJUH- Rahway and Saint Barnabas Medical Center in Livingston; three acute care children’s hospitals and a leading pediatric rehabilitation hospital (Children’s Specialized Hospital), a freestanding 100-bed behavioral health center, ambulatory care centers, geriatric centers, the state’s largest behavioral health network, comprehensive home care and hospice programs, fitness and wellness centers, retail pharmacy services, a medical group, multi-site imaging centers and four accountable care organizations.
RWJBarnabas Health is New Jersey’s second largest private employer – with more than 32,000 employees, 9,000 physicians and 1,000 residents and interns – and routinely captures national awards for its outstanding quality and safety.
About Robert Wood Johnson University Hospital
Robert Wood Johnson University Hospital (RWJUH) is a 965-bed academic medical center with campuses in New Brunswick and Somerville, N.J. Its Centers of Excellence include cardiovascular care from minimally invasive heart surgery to transplantation, cancer care, stroke care, neuroscience, joint replacement, and women’s and children’s care, including The Bristol-Myers Squibb Children’s Hospital at RWJUH(www.bmsch.org). As the flagship Cancer Hospital of Rutgers Cancer Institute of New Jersey and the principal teaching hospital of Rutgers Robert Wood Johnson Medical School in New Brunswick, RWJUH is an innovative leader in advancing state-of-the-art care.
As a Level I Trauma Center and the first Pediatric Trauma Center in the state, RWJUH’s New Brunswick campus serves as a national resource in its ground-breaking approaches to emergency preparedness.
RWJUH has been ranked among the best hospitals in America by U.S. News & World Report seven times and has been selected by the publication as a high performing hospital in numerous specialties. The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital has been ranked among the best hospitals in America by U.S. News & World Report for three consecutive years.
Both the New Brunswick and Somerset campuses have earned significant national recognition for clinical quality and patient safety, including the prestigious Magnet® Award for Nursing Excellence and “Most Wired” designation by Hospitals and Health Networks magazine. The Joint Commission and the New Jersey Department of Health and Senior Services have designated the New Brunswick Campus as a Comprehensive Stroke Center and the Somerset Campus as a Primary Stroke Center.
The American College of Surgeons’ Commission on Cancer has rated RWJUH New Brunswick among the nation’s best comprehensive cancer centers and designated the Steeplechase Cancer Center at RWJUH Somerset as a Comprehensive Community Cancer Center. The Joint Surgery Center at Robert Wood Johnson University Hospital Somerset has earned the Joint Commission’s Gold Seal of Approval for total knee and total hip replacement surgery.
Robert Wood Johnson University Hospital is ranked no. 19 in Diversity MBA Magazine’s 2015 rankings for “50 Out Front Companies for Diversity Leadership: Best Places for Women & Diverse Managers to Work” and also is recognized by the magazine in its “Top 10 Best in Class: Succession Planning and Accountability.”